tradmap

VCYT Veracyte, Inc.

$44.64 -0.65%

Updated

Healthcare · Services-Medical Laboratories

Veracyte, Inc. (VCYT) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $3.6 billion. Shares last traded at $44.64, 27.6% below their 52-week high. Over the past year the stock is up 45.6%. VCYT trades at a price-to-earnings ratio of 31.35, above the Services-Medical Laboratories median of 26.82. Net profit margin is 20.4%, above the peer median of -5.4%. Revenue grew 16.0% year over year.

Market Cap
$3.6B
Shares Out
80.4M
EPS (TTM)
$1.41
P/E Ratio
31.66
P/S Ratio
6.39
P/B Ratio
2.58
Dividend / Share
Dividend Yield
52-Week High
$61.70
52-Week Low
$29.45
Volume
33,473
Avg Vol (3m)
73,621.365

Performance

1W
-1.33%
1M
-3.17%
3M
-10.68%
6M
+28.79%
YTD
+5.36%
1Y
+45.64%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
46.33
SMA (50)
$50.92
SMA (200)
$42.61
Price vs SMA50
-12.34%
Price vs SMA200
+4.77%
ATR (14)
$2.19

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$562M
Net Income
$114M
Gross Margin
71.7%
Operating Margin
18.8%
Net Margin
20.4%
Return on Equity
8.2%
Return on Assets
7.7%
Current Ratio
9.16
Debt / Equity
0.00
Revenue Growth (YoY)
+16.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.66 2026-07-31
Q1 2026 $0.35 2026-05-06
FY 2025 $0.82 2026-02-26
Q3 2025 $0.32 2025-11-05
Q2 2026 $0.08 2026-07-31
Q1 2026 $0.09 2026-05-06

Full earnings history →

Services-Medical Laboratories peers

VCYT vs 14 industry peers (Services-Medical Laboratories), by market cap. Updated

P/E vs peers
31.35 / 26.82 med
+17% premium
P/S vs peers
6.39 / 2.75 med
+132% premium
Net margin vs peers
20.4% / -5.4% med
above median
1–14 of 14
NTRANatera, Inc.$47.2B-245.2617.43-7.1%+0.66%
LHLabcorp$26.9B26.821.877.0%-0.07%
DGXQuest Diagnostics$26.4B24.882.299.2%-0.58%
GHGuardant Health, Inc.$21.6B-47.6518.26-38.3%-1.23%
CAICaris Life Sciences, Inc.$7.2B68.067.2310.6%+2.14%
RDNTRadnet, Inc.$5.9B-278.182.59-0.9%-1.36%
CELCCelcuity Inc.$4.7B-20.82+0.06%
BLLNBilliontoone, Inc.$4.6B121.8611.569.5%+3.64%
GRALGrail, Inc.$3.6B-9.19+0.03%
VCYTVeracyte, Inc.$3.6B31.356.3920.4%-0.65%
CDNACaredx, Inc.$2.6B23.225.6324.2%+0.44%
PSNLPersonalis, Inc.$1.8B-16.77+0.51%
FTREFortrea Holdings Inc.$1.8B-20.770.66-3.2%+1.47%
LMRILumexa Imaging Holdings, Inc.$1.1B-1.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.